F060 Young Physician Pearls and Pitfalls: A Survival Guide For the First 10 Years
DESCRIPTION
This session will explore the many professional opportunities available to dermatologists within and beyond the practice of clinical medicine. It will explore academic and private practice careers, collaboration with industry, and personal leadership development for early career dermatologists.
LEARNING OBJECTIVES
Identify the professional opportunities available to dermatologists within and beyond the practice of clinical medicine.
Understand the basics when seeking employment and negotiating a contract.
Explore the opportunities for leadership, advocacy, and personal development available to early career dermatologists through the AAD and other organizations.
SCHEDULE
3:30 PM
Welcome and Introductions
Tanya Greywal, MD, FAAD
3:35 PM
Job Hunting: The Basics to Consider
Tanya Greywal, MD, FAAD
3:50 PM
Contract Negotiation
Vineet Mishra, MD, FAAD
4:00 PM
Q&A (Drs. Greywal and Mishra)
Tanya Greywal, MD, FAAD, Vineet Mishra, MD, FAAD
4:05 PM
Considerations for an Academic Career
Anna Cristina Garza-Mayers, MD, PhD, FAAD
4:25 PM
Putting Up Your Own Shingle
Aislyn Nelson, MD, PhD, FAAD
4:45 PM
Q&A (Drs. Garza-Mayers and Nelson)
Anna Cristina Garza-Mayers, MD, PhD, FAAD, Aislyn Nelson, MD, PhD, FAAD
4:50 PM
Owning It: Leadership, Advocacy, and Development as a Young Physician
Bridget McIlwee, DO, FAAD
5:05 PM
Interacting with Industry
David Cotter, MD, PhD, FAAD
5:25 PM
Q&A (Drs. McIlwee and Cotter)
David Cotter, MD, PhD, FAAD, Bridget McIlwee, DO, FAAD
DIRECTOR
Tanya Greywal, MD, FAAD
University of Washington / Seattle Children's Hospital
SPEAKERS
David Cotter, MD, PhD, FAAD
Anna Cristina Garza-Mayers, MD, PhD, FAAD
Bridget McIlwee, DO, FAAD
Vineet Mishra, MD, FAAD
Aislyn Nelson, MD, PhD, FAAD
HANDOUTS
DISCLOSURES
David Cotter, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees), Speaker(Honoraria); Alumis – Advisory Board(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Blueprint Medicines – Advisory Board(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Castle Biosciences – Investigator(Fees), Speaker(Honoraria), Speaker/Faculty Education(Honoraria); DermTech Inc. – Speaker(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma – Speaker(Honoraria); Incyte – Advisory Board(Honoraria); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria), Investigator(Fees), Speaker(Honoraria); Novartis – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Organon – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Investigator(Fees); Sanofi/Regeneron – Speaker(Honoraria); Thermo Fischer Scientific – Investigator(Fees); UCB – Advisory Board(Honoraria); Veradermics – Consultant (1099 relationship)(Honoraria);
Anna Cristina Garza-Mayers, MD, PhD, FAAD
Incyte – Investigator(No Compensation Received); Sanofi – Investigator(No Compensation Received); Sanofi/Regeneron – Advisory Board(Honoraria);
Tanya Greywal, MD, FAAD
No financial relationships exist with ineligible companies.
Bridget McIlwee, DO, FAAD
No financial relationships exist with ineligible companies.
Vineet Mishra, MD, FAAD
No financial relationships exist with ineligible companies.
Aislyn Nelson, MD, PhD, FAAD
No financial relationships exist with ineligible companies.